drugset / Trial / NCT02660372
Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is to show non-inferiority of two brands of simeticone in adult patients suffering from functional dyspepsia.
Timeline
- Start
- 2016-02
- Primary completion
- 2016-10
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Simethicone | Other / unclassified | 40 mg | — |
| Comparator | Simethicone | Other / unclassified | 120 mg | — |